NLS Pharmaceutics Ltd (NLSP)
0.1139
0.00 (0.00%)
USD |
NASDAQ |
Jun 14, 16:00
0.114
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
AC Immune SA | 1.172M |
CRISPR Therapeutics AG | 109.75M |
Addex Therapeutics Ltd | -2.511M |
Molecular Partners AG | -19.51M |
MoonLake Immunotherapeutics | -14.95M |
Cash from Operations (Quarterly) Related Metrics
Free Cash Flow | -9.684M |
Free Cash Flow Yield | -222.7% |